Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01285440 · ClinicalTrials.gov registry record
Use of Low-dose Molecular Breast Imaging for the Detection of Small Breast Lesions
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 150
- Enrollment target
NCT01285440: Completed study, sponsored by Mayo Clinic.
NCT01285440 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01285440 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to show that improvements in the molecular breast imaging (MBI) technology will allow reduction of the administered dose of Tc-99m sestamibi while maintaining a sensitivity of 90% for tumor detection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2010-03 |
| Est. Completion | 2016-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01285440
The ClinicalTrials.gov registry entry for NCT01285440 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01285440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01285440 about?
NCT01285440 is a clinical study titled "Use of Low-dose Molecular Breast Imaging for the Detection of Small Breast Lesions". The purpose of this study is to show that improvements in the molecular breast imaging (MBI) technology will allow reduction of the administered dose of Tc-99m sestamibi while maintaining a sensitivity of 90% for tumor detection.
What is the current status of trial NCT01285440?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2010-03. Estimated completion is 2016-12-01.
Who is sponsoring clinical trial NCT01285440?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.